Drug Profile
Cyclotriazadisulfonamide
Alternative Names: CADALatest Information Update: 22 Aug 2007
Price :
$50
*
At a glance
- Originator Nonindustrial source; Rega Institute for Medical Research; University of Nevada Reno
- Class Antivirals
- Mechanism of Action CD4 antigen inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Herpesvirus infections; HIV infections